DailyDoctor Archive Specialties Get app
All radiology briefings

The edition · Radiology

After five stable years, low-risk pancreatic cysts carried an 8-year cancer risk under 1%

A 13,269-patient review of reports compared the ACR, Kyoto and European cyst guidelines and followed stable cysts beyond surveillance. Plus photon-counting CT inside coronary stents, what germline variants look like on prostate MRI, and whether the ellipsoid formula is good enough for PSA density.

The edition in brief

In 13,269 patients with pancreatic cysts at one US centre, 1.6% developed cancer or high-grade dysplasia within five years. The ACR, Kyoto and European guidelines predicted this modestly (AUROC 0.62 to 0.66), agreed completely on high-risk cysts, and disagreed on which cysts had worrisome features. Among 1,830 patients whose cysts were stable for five years, eight-year cancer incidence was 0.71%, and 0.46% in those meeting Kyoto criteria to stop surveillance. A single-centre study of 70 patients found photon-counting CT made almost all coronary stents assessable (1.1% nondiagnostic vs 46.8% with conventional CT) and missed no in-stent restenosis, though positive predictive value per stent was 56%. Men with prostate cancer carrying germline pathogenic variants were more likely to have PI-RADS 5 lesions (OR 2.7) and upgrading at prostatectomy (37% vs 20%). The PI-RADS ellipsoid volume matched manual segmentation closely (ICC 0.985) in 328 men, underestimating glands over 80 cc.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for radiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free